Nutraceutical Regulations & Registration In The European Union (EU): A Complete Compliance Guide For 2025

The European nutraceutical market continues to expand rapidly, driven by rising consumer awareness around preventive healthcare, functional nutrition, healthy ageing, immunity support, and scientifically backed wellness products. Europe remains one of the world’s most valuable nutraceutical markets, supported by strong consumer demand, advanced healthcare systems, and increasing interest in plant-based and bioactive ingredients.

However, market opportunity comes with significant regulatory complexity.

In the European Union (EU), nutraceuticals are regulated under:

EU Food & Dietary Supplement Laws

rather than pharmaceutical legislation. This means companies must comply with:

• EU food regulations 
• EFSA scientific requirements 
• National notification systems 
• Strict health claims rules 
• Labeling and safety obligations 

Failure to understand the correct regulatory pathway may result in:

• Product launch delays 
• Enforcement actions 
• Health claim rejection 
• Import restrictions 
• Product withdrawals 
• Commercial and reputational risk 

This comprehensive guide from Maven Regulatory Solutions explains nutraceutical regulations and registration requirements in the European Union, including legal frameworks, EFSA expectations, labeling obligations, notification procedures, and practical compliance strategies for 2025.

Understanding How Nutraceuticals Are Classified In The EU

In the European Union, nutraceuticals are generally classified as:

Food Supplements / Dietary Supplements

and are regulated under EU food legislation rather than medicinal product law.

This distinction is critical because:

• Nutraceuticals are not approved by the European Medicines Agency (EMA) 
• Oversight is managed by competent national authorities 
• Scientific evaluations are performed by the European Food Safety Authority (EFSA) 

The regulatory classification directly affects:

• Product positioning 
• Claims strategy 
• Labeling requirements 
• Scientific substantiation 
• Market access pathways 

Definition Of Food Supplements Under EU Law

Under:

Directive 2002/46/EC

food supplements are defined as:

“Concentrated sources of nutrients or other substances with a nutritional or physiological effect, intended to supplement the normal diet.”

These products are typically marketed in dose forms such as:

• Capsules 
• Tablets 
• Powders 
• Sachets 
• Gummies 
• Liquids 
• Soft gels 

EU Regulatory Framework Governing Nutraceuticals

Nutraceuticals in Europe are regulated through several interconnected legislative frameworks.

Core EU Nutraceutical Regulations

Together, these regulations govern:

• Ingredient safety 
• Labeling 
• Claims 
• Manufacturing 
• Market notification 
• Consumer protection 

1. Regulation (EU) No 1169/2011 – Food Information To Consumers (FIC)

The:

Food Information to Consumers (FIC) Regulation

establishes mandatory labeling and consumer information requirements.

Key Labeling Requirements

Labels must be:

• Clear 
• Accurate 
• Legible 
• Scientifically supportable 
• Non-misleading 

2. Directive 2002/46/EC – Food Supplements Directive

This directive forms the foundation of EU nutraceutical regulation.

Key Regulatory Provisions

The directive primarily addresses:

• Vitamins 
• Minerals 

while other ingredients such as:

• Botanicals 
• Probiotics 
• Amino acids 
• Bioactive compounds 

may also fall under:

• National laws 
• Novel Food regulations 
• Additional EFSA scrutiny 

3. Regulation (EC) No 1924/2006 – Nutrition & Health Claims

Health claims are one of the most tightly regulated areas in the EU nutraceutical market.

Key Principles of EU Health Claims Regulation

Only:

EFSA-approved health claims

may appear on product labeling, advertising, websites, or promotional materials.

Common Types of Permitted Claims

Examples include:

• “Contributes to normal immune function” 
• “Supports normal bone health” 
• “Contributes to reduction of tiredness and fatigue” 

However, statements suggest:

• Treatment 
• Prevention 
• Cure of disease 

are prohibited unless the product is regulated as a medicinal product.

Novel Food Regulation in Nutraceuticals

Certain ingredients require authorization under:

Regulation (EU) 2015/2283 – Novel Food Regulation

if they were not significantly consumed in the EU before May 15, 1997.

Common Novel Food Categories

Novel Food authorization often requires:

• Toxicological data 
• Stability studies 
• Exposure assessment 
• Safety dossiers 
• EFSA scientific evaluation 

Documents Required for EU Nutraceutical Registration

Although the EU does not operate a centralized nutraceutical registration system, most Member States require:

Product Notification Before Market Entry

1. Product Information

Required product details typically include:

• Product name 
• Brand name 
• Product category 
• Intended use 
• Dosage form 
• Target population 
• Recommended daily intake 

2. Ingredient & Composition Information

Required Ingredient Documentation

Ingredient transparency is increasingly important across the EU market.

3. Safety Assessment Documentation

Manufacturers may need to provide:

• Toxicological assessments 
• Ingredient history of safe use 
• Exposure calculations 
• Interaction assessments 
• EFSA opinions 
• Scientific literature 

Safety substantiation is particularly important for:

• High-dose formulations 
• Botanical extracts 
• Novel ingredients 

4. Quality & Manufacturing Documentation

Common Manufacturing Requirements

EU regulators increasingly expect:

Strong quality systems and traceability controls

5. Labeling & Packaging Documentation

Manufacturers must provide:

• Label artwork 
• Packaging drafts 
• Warning statements 
• Claim substantiation 
• Usage instructions 

All labels must align with:

• EU FIC regulation 
• National language requirements 
• Claims regulation standards 

6. Scientific Evidence for Health Claims

Where claims are used, companies may need:

• EFSA-authorized claim references 
• Clinical literature 
• Functional evidence 
• Mechanistic support 

Scientific substantiation remains central to EU nutraceutical compliance.

EU Nutraceutical Labeling Requirements

Mandatory Labeling Elements

Labels must avoid:

• Therapeutic positioning 
• Misleading claims 
• Pharmaceutical-style messaging 

EU Nutraceutical Registration Process: Step-By-Step

Step 1 – Ingredient Eligibility Assessment

Manufacturers must verify whether ingredients are:

• Permitted under EU law 
• Subject to Novel Food status 
• Restricted nationally 

Step 2 – Formulation Compliance Review

Regulatory review includes:

• Nutrient levels 
• Bioavailability 
• Stability 
• Exposure limits 

Step 3 – Safety Assessment

Safety evaluations may include:

• Toxicological assessment 
• Vulnerable population analysis 
• Scientific literature review 
• Exposure calculations 

Step 4 – Label & Claims Compliance Review

Claims must align with:

• EFSA-authorized wording 
• Scientific substantiation 
• Consumer protection standards 

Step 5 – National Authority Notification

Most EU Member States require:

Pre-market notification

before commercialization.

Requirements vary by country.

Step 6 – Cross-Border EU Market Access

Under:

The Principle of Mutual Recognition

products legally marketed in one Member State may generally be sold across other EU countries, subject to:

• Local notification rules 
• Language adaptation 
• Country-specific requirements 

Recent EU Nutraceutical Regulatory Trends (2024–2025)

Regulatory scrutiny across the EU continues increasing.

Key Emerging Trends

Authorities are also increasing focus on:

• Sustainability 
• Supply chain transparency 
• Ingredient traceability 
• Consumer protection 

Common Compliance Challenges for Nutraceutical Brands

Organizations frequently encounter challenges involving:

• Incorrect product classification 
• Unapproved health claims 
• Novel ingredient uncertainty 
• Label non-compliance 
• Cross-border notification complexity 
• Botanical safety concerns 
• EFSA substantiation requirements 

Early regulatory strategy significantly reduces commercialization risk.

Why EU Nutraceutical Compliance Matters

Failure to comply with EU nutraceutical regulations may result in:

• Product recalls 
• Import refusals 
• Administrative penalties 
• Health claim restrictions 
• Market access limitations 
• Reputational harm 

Regulatory compliance is increasingly becoming a competitive differentiator in the European wellness market.

How Maven Regulatory Solutions Supports EU Nutraceutical Compliance

Our Services

• EU nutraceutical classification strategy 
• Ingredient and Novel Food assessments 
• EFSA health claim support 
• Labeling and artwork compliance 
• Member State notification management 
• Cross-border EU market access planning 
• Scientific substantiation support 
• GMP and quality compliance consulting 

Why Choose Maven

• Deep EU regulatory expertise 
• Practical commercialization focus 
• Integrated scientific and regulatory approach 
• Strong nutraceutical industry experience 
• Up-to-date EFSA and EU intelligence 
• End-to-end lifecycle support 

Our approach supports:

• Faster market access 
• Reduced regulatory risk 
• Stronger claim defensibility 
• Sustainable compliance strategy 
• Long-term commercial success 

Need Support Navigating EU Nutraceutical Regulations?

Whether you are planning EU market entry, evaluating Novel Food status, preparing EFSA health claim strategies, or managing Member State notifications, Maven Regulatory Solutions can help simplify your European compliance pathway.

Contact Maven Regulatory Solutions For:

• EU nutraceutical registration strategy 
• Ingredient and safety assessments 
• EFSA health claim support 
• Labeling and packaging compliance 
• Novel Food Regulatory Consulting 
• Cross-border EU market access planning 
• Scientific substantiation review 

Visit Maven Regulatory Solutions to connect with our nutraceutical regulatory experts today.

Conclusion

The European Union remains one of the world’s most attractive yet highly regulated nutraceutical markets. Success requires more than innovative formulations it demands scientifically grounded, strategically planned, and fully compliant regulatory execution.

Organizations that proactively align with:

• EU food law 
• EFSA expectations 
• Health claims regulation 
• Novel Food requirements 
• Labeling standards 

will be best positioned to achieve sustainable growth and long-term market access across Europe.

Maven Regulatory Solutions partners with nutraceutical and wellness brands worldwide to support compliant EU market entry through expert regulatory strategy, scientific guidance, and end-to-end compliance support.

Frequently Asked Questions 

Q1. Are nutraceuticals regulated by EMA in the EU?

No. Nutraceuticals are regulated under EU food law and overseen by national authorities with scientific input from EFSA.

Q2. Do nutraceuticals require centralized EU approval?

No. Most products are handled through Member State notification systems.

Q3. Are health claims allowed on nutraceuticals?

Yes, but only if the claims are authorized by EFSA and comply with EU regulations.

Q4. Can nutraceuticals make disease treatment claims?

No. Disease prevention, treatment, or cure claims are prohibited for food supplements.

Q5. What is a Novel Food ingredient?

An ingredient not significantly consumed in the EU before May 15, 1997, may require Novel Food authorization.

Q6. Can one EU notification support all Member States?

Generally, products may benefit from mutual recognition, but local notification and language requirements still apply.

Q7. How can Maven support EU nutraceutical registration?

Maven provides classification support, ingredient assessment, EFSA claim strategy, labeling review, notification management, and market access consulting.